2,6-Dichlorobenzaldoxime

We are 2,6-Dichlorobenzaldoxime CAS:25185-95-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 25185-95-9
Product Name: 2,6-Dichlorobenzaldoxime
Other Name:
2,6-Dichlorobenzaldoxime
(NE)-N-[(2,6-dichlorophenyl)methylidene]hydroxylamine
2,6-dichloro-benzaldehyde oxime
2,6-Dichlorobenzaldehyde oxime
 
Density: 1.38 g/cm3
Boiling Point: 280.4ºC at 760 mmHg
Melting Point: 147 °C
Molecular Formula: C7H5Cl2NO
Molecular Weight: 190.02700
Flash Point: 123.4ºC
Exact Mass: 188.97500
PSA: 32.59000
LogP: 2.80150
Vapour Pressure: 0.0018mmHg at 25°C
Index of Refraction: 1.575
 
Specification
Appearance: Light gray crystalline powder
Assay: ≥99.0%
Water: ≤0.5%
 
Application
Intermediates of Lufenuron CAS: 103055-07-8.
Intermediates of Chlorfluazuron CAS: 71422-67-8.
Intermediates of Diflubenzuron CAS: 35367-38-5.
Intermediates of Hexaflumuron CAS: 86479-06-3.
2,6-Dichlorobenzaldehyde oxime is an important intermediate in the synthesis of benzoyl urea pesticides, and is used to synthesize the next intermediate 2,6-dichlorobenzonitrile which is used to the synthesis of flubenzuron, diflubenzuron, fluaziridine, and fenflubenzuron, etc. In addition, 2,6-dichlorobenzaldehyde oxime is also a pharmaceutical intermediate used to produce diclofenac penicillin sodium.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,6-Dichlorobenzaldoxime


Related News: With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.1112-39-6 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Polisiloxanos di-Me Me hidrógeno CAS:68037-59-2 Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.7-(3-Chloropropoxy)-6-methoxy-4-oxo-1,4-dihydro-3-quinolinecarbon itrile CAS:214470-66-3 Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.

Related Products
Product Name
N-Boc-L-serine Methyl Ester View Details
2,5-Difluorobenzaldehyde View Details
2,6-Dichloro-3-Iodopyridine View Details
6-chloro-7H-purine manufacturer 2-Fluoro-3-methylpyridine manufacturer Triphenylantimony Dichloride manufacturer 1,2-Difluoro-4-methyl-5-nitrobenzene manufacturer 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid manufacturer